Efficacy of Letermovir in Preventing Cytomegalovirus (CMV) Infection in Lung Transplant Recipients vs. Valganciclovir.
Condition: Infections, Cytomegalovirus Intervention: Drug: Letermovir 240 mg Oral Tablet Sponsors: Maimónides Biomedical Research Institute of Córdoba; MERCK SHARP & DOHME DE ESPAÑA S.A. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials